Novel parameters determining the risk of coronary artery disease

References (9)

1. Demirci H, Aydın U, Budak YÜ, Çınar Y. Koroner arter hastalarında bir risk belirleyicisi olarak hesaplanan serum osmolalite değeri. Türkiye Aile Hekimliği Dergisi 2015; 19: 31-36
2. Siti HN, Yusof K, Kamsiah J. The role of oxidative stress, antioxidants and vascular inflammaton in cardiovascular disease. Vascul Pharmacol 2015. pii: S1537-1891(15) 00042-7
3. Akboga MK, Canpolat U, Sahinarslan A, et al. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation. Atherosclerosis 2015; 240: 110-4
4. Doganer YC, Aydogan U, Aydogdu A, et al. Relationship of cystatin C with coronary artery disease and its severity. Coron Artery Dis 2013; 24: 119-26
5. Doganer YC, Aydogan U, Aparci M, et al. Comparison of cystatin-C and pentraxin-3 in coronary atherosclerosis. Coron Artery Dis 2014; 25: 589-94
6. Lubrano V, Balzan S. Consolidated and emerging inflammatory markers in coronary artery disease. World J Exp Med 2015; 5: 21-32
7. Tokgozoglu L. Atherosclerosis and the role of inflammation. Turk Kardiyol Dern Ars 2009; 37 Suppl 4: 1-6
8. Kardeşoğlu E, Aparci M. Salt Intake in Cardiovascular Disease. Turkiye Klinikleri Journal of Cardiology Special Topics 2010; 3: 27
9. Satoh K, Fukumoto Y, Sugimura K, et al. Plasma cyclophilin A is a novel biomarker for coronary artery disease. Circ J 2013; 77: 447-55.